Vimarsana
Biggest News Aggregation in the World

Page 9 - Cell Pouch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Pouch Today - Breaking & Trending Today

Sernova Corp. (OTCMKTS:SEOVF) Short Interest Up 38.2% in March - Vimarsana News

Sernova Corp. (OTCMKTS:SEOVF) Short Interest Up 38.2% in March

Should You Buy or Sell Sernova Stock? Get The Latest SEOVF Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.

Source: wkrb13.com
Short Interest in Sernova Corp. (OTCMKTS:SEOVF) Rises By 38.2% - Vimarsana News

Short Interest in Sernova Corp. (OTCMKTS:SEOVF) Rises By 38.2%

Sernova Corp. (OTCMKTS:SEOVF – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 161,800 shares, an increase of 38.2% from the March 15th total of 117,100 shares. Based on an average trading volume of 48,000 shares, the days-to-cover […]

Critical Comparison: Sernova (OTCMKTS:SEOVF) and Alnylam Pharmaceuticals (NASDAQ:ALNY) - Vimarsana News

Critical Comparison: Sernova (OTCMKTS:SEOVF) and Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) and Sernova (OTCMKTS:SEOVF – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares Alnylam Pharmaceuticals and Sernova’s net margins, return […]

Sernova Corp.: Institutional Shareholder Services Inc. Recommends Senova's Shareholders Vote FOR all Management Nominees on Management's White Proxy - Vimarsana News

Sernova Corp.: Institutional Shareholder Services Inc. Recommends Senova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

ISS, an independent, third-party proxy advisory firm, recommends Sernova's shareholders vote FOR all management's director nominees using ONLY management's WHITE proxy.ISS notes the dissidents failed to

EQS-News: Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes Seite 1 - Vimarsana News

EQS-News: Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes Seite 1

08.03.2023 - Issuer: Sernova Corp. / Key word(s): Study/Study results Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes 08.03.2023 / 13:05 ... Seite 1